In This Section

AACR Virtual Patient Advocate Forum: A New Frontier— The Very Early Detection of Cancer Signals

Tuesday, October 11, 2022; 1 – 3:30 p.m. ET/ 10 a.m. – 12:30 p.m. PT

Register Today Forum Agenda

Late-stage diagnosis is a major contributor to cancer-related mortality, as patients diagnosed with advanced cancers have fewer treatment options and a greater likelihood of death. Early detection of cancer may, therefore, help reduce cancer-related mortality around the world. Screening programs for breast, colorectal, and cervical cancers have demonstrated the power of early cancer detection. Despite these successes, easy screening methods are currently unavailable for some of the world’s deadliest cancers and there is substantial debate on the potential of screening tests to identify early “signals” for multiple cancers to cause unintended harm. This Patient Advocate Forum will highlight the latest research in cancer’s very early detection, as well as discuss the benefits and potential negatives of these new cancer screening tests.


Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine


Timothy R. Rebbeck, PhD, Dana Farber Cancer Institute

Anjee Q. Davis, MPPA, Fight Colorectal Cancer

Philip E. Castle, PhD, MPH, National Cancer Institute

C. Jimmy Lin, MD, PhD, MHS, Freenome

Ruth B. Etzioni, PhD, Fred Hutchinson Cancer Research Center